why choose us

Clinical Trials Search

Showing 9,450 of 132,366 result(s)
Allogeneic BM-MSC's in Patients With Lumbar Facet Arthropathy

Status: Completed

Condition: Facet-Mediated Low Back Pain

Interventions: BM-MSCs at the dose 10 x 106 in 1 ml per facet joint for a total of 2 joints

Date: 2023-07-26

A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors

Status: Completed

Condition: Head and Neck Cancer

Interventions: Escalating doses of TSC-204-A0201 as a monotherapy

Date: 2023-07-25

Randomized Blinded Evaluation of the Effects of TENS and IFC Compared to a Sham Device and SOC in Patients With Non-Specific CLBP

Status: Completed

Condition: Non-Specific Chronic Lower Back Pain

Interventions: Device subjects receive designated treatment mode twice daily for up to 8 weeks.

Date: 2023-07-25

Adapting CBT-I for Hazardous Alcohol Users

Status: NOT_YET_RECRUITING

Condition: Insomnia

Interventions: The Insomnia Treatment is a version of Cognitive Behavioral Therapy for Insomnia adapted to individuals with hazardous alcohol use.
It consists o

Date: 2023-07-25

Oxygen-guided Supervised Exercise Therapy

Status: Completed

Condition: Peripheral Artery Disease

Interventions: Subjects will be enrolled in a 12-week intervention program of either modified supervised exercise therapy or standard supervised exercise therapy.

Date: 2023-07-25

Storytelling for Reducing Gap in Anticoagulation Use in African Americans With Atrial Fibrillation

Status: NOT_YET_RECRUITING

Condition: Atrial Fibrillation

Interventions: Participants assigned to the intervention group will watch videos presenting stories of African American patients about their experiences with using a

Date: 2023-07-25

CW2IP2: Imaging and Diagnostic Assessments

Status: Completed

Condition: Tauopathies

Interventions: Positron Emission Tomography (PET) scan using either Florbetaben F18 or 11C-PiB radiotracer

Date: 2023-07-25

Study to Evaluate the Efficacy and Safety of Oral Difelikefalin for Moderate to Severe Pruritus in Subjects With Notalgia Paresthetica

Status: Completed

Condition: Pruritus

Interventions: Oral difelikefalin 2.0 mg administered twice daily

Date: 2023-07-25

Study of 11C-HY-2-15

Status: Completed

Condition: Tauopathies

Interventions: 2 hour Positron Emission Tomography (PET) scan using new radiotracer 11C-HY-2-15

Date: 2023-07-25

A Phase 2 Study of CRG-022 in Patients With Relapsed;Refractory Large B-cell Lymphoma

Status: Completed

Condition: Cancer

Interventions: Lymphodepletion chemotherapy

Date: 2023-07-25